{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T12:26:14Z","timestamp":1790857574223,"version":"4.1.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:00:00Z","timestamp":1760659200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:00:00Z","timestamp":1760659200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-20350-w","type":"journal-article","created":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T15:08:04Z","timestamp":1760713684000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["CH7450924, a KEAP1-NRF2 interaction inhibitor, ameliorates LPS-induced multiple organ dysfunction via inflammatory pathway inhibition"],"prefix":"10.1038","volume":"15","author":[{"given":"Masaki","family":"Hoshino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukari","family":"Yasui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shun","family":"Mitsumata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Kawauchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryuichi","family":"Komatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Kimbara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoshi","family":"Horiba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,17]]},"reference":[{"key":"20350_CR1","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1177\/0885066619871452","volume":"35","author":"NM Gourd","year":"2020","unstructured":"Gourd, N. M. & Nikitas, N. Multiple organ dysfunction syndrome. J. Intensive Care Med. 35, 1564\u20131575 (2020).","journal-title":"J. Intensive Care Med."},{"key":"20350_CR2","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/j.ajem.2007.10.031","volume":"26","author":"H Wang","year":"2008","unstructured":"Wang, H. & Ma, S. The cytokine storm and factors determining the sequence and severity of organ dysfunction in multiple organ dysfunction syndrome. Am. J. Emerg. Med. 26, 711\u2013715 (2008).","journal-title":"Am. J. Emerg. Med."},{"key":"20350_CR3","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/S0140-6736(19)32989-7","volume":"395","author":"KE Rudd","year":"2020","unstructured":"Rudd, K. E. et al. Global, regional, and national sepsis incidence and mortality, 1990\u20132017: Analysis for the global burden of disease study. Lancet 395, 200\u2013211 (2020).","journal-title":"Lancet"},{"key":"20350_CR4","doi-asserted-by":"publisher","first-page":"2408","DOI":"10.1097\/01.CCM.0000282072.56245.91","volume":"35","author":"E Abraham","year":"2007","unstructured":"Abraham, E. & Singer, M. Mechanisms of sepsis-induced organ dysfunction. Crit. Care Med. 35, 2408\u20132416 (2007).","journal-title":"Crit. Care Med."},{"key":"20350_CR5","doi-asserted-by":"publisher","first-page":"e1063","DOI":"10.1097\/CCM.0000000000005337","volume":"49","author":"L Evans","year":"2021","unstructured":"Evans, L. et al. Surviving sepsis campaign: International guidelines for management of sepsis and septic shock 2021. Crit. Care Med. 49, e1063\u2013e1143 (2021).","journal-title":"Crit. Care Med."},{"key":"20350_CR6","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1152\/physrev.00023.2017","volume":"98","author":"M Yamamoto","year":"2018","unstructured":"Yamamoto, M., Kensler, T. W. & Motohashi, H. The KEAP1-NRF2 system: A thiol-based sensor-effector apparatus for maintaining redox homeostasis. Physiol. Rev. 98, 1169\u20131203 (2018).","journal-title":"Physiol. Rev."},{"key":"20350_CR7","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.bbrc.2006.10.102","volume":"351","author":"RK Thimmulappa","year":"2006","unstructured":"Thimmulappa, R. K. et al. Nrf2-dependent protection from LPS induced inflammatory response and mortality by CDDO-Imidazolide. Biochem. Biophys. Res. Commun. 351, 883\u2013889 (2006).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"20350_CR8","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1172\/JCI25790","volume":"116","author":"RK Thimmulappa","year":"2006","unstructured":"Thimmulappa, R. K. et al. Nrf2 is a critical regulator of the innate immune response and survival during experimental sepsis. J. Clin. Invest. 116, 984\u2013995 (2006).","journal-title":"J. Clin. Invest."},{"key":"20350_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2023.104480","volume":"90","author":"Y Wang","year":"2023","unstructured":"Wang, Y. et al. A small-molecule inhibitor of Keap1-Nrf2 interaction attenuates sepsis by selectively augmenting the antibacterial defence of macrophages at infection sites. EBioMedicine 90, 104480 (2023).","journal-title":"EBioMedicine"},{"key":"20350_CR10","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s10753-017-0689-z","volume":"41","author":"AD Giustina","year":"2018","unstructured":"Giustina, A. D. et al. Dimethyl fumarate modulates oxidative stress and inflammation in organs after sepsis in rats. Inflammation 41, 315\u2013327 (2018).","journal-title":"Inflammation"},{"key":"20350_CR11","doi-asserted-by":"publisher","first-page":"182","DOI":"10.3892\/ijmm.2015.2396","volume":"37","author":"T Qi","year":"2016","unstructured":"Qi, T., Xu, F., Yan, X., Li, S. & Li, H. Sulforaphane exerts anti-inflammatory effects against lipopolysaccharide-induced acute lung injury in mice through the Nrf2\/ARE pathway. Int. J. Mol. Med. 37, 182\u2013188 (2016).","journal-title":"Int. J. Mol. Med."},{"key":"20350_CR12","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1164\/rccm.201102-0271OC","volume":"184","author":"X Kong","year":"2011","unstructured":"Kong, X. et al. Enhancing Nrf2 pathway by disruption of Keap1 in myeloid leukocytes protects against sepsis. Am. J. Respir. Crit. Care Med. 184, 928\u2013938 (2011).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"20350_CR13","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1093\/toxsci\/kfn079","volume":"104","author":"WO Osburn","year":"2008","unstructured":"Osburn, W. O. et al. Genetic or pharmacologic amplification of Nrf2 signaling inhibits acute inflammatory liver injury in mice. Toxicol. Sci. 104, 218\u2013227 (2008).","journal-title":"Toxicol. Sci."},{"key":"20350_CR14","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1107\/S174430911301124X","volume":"69","author":"S H\u00f6rer","year":"2013","unstructured":"H\u00f6rer, S., Reinert, D., Ostmann, K., Hoevels, Y. & Nar, H. Crystal-contact engineering to obtain a crystal form of the kelch domain of human keap1 suitable for ligand-soaking experiments. Acta Crystallogr. Sect. F Struct. Biol. Cryst. Commun. 69, 592\u2013596 (2013).","journal-title":"Acta Crystallogr. Sect. F Struct. Biol. Cryst. Commun."},{"key":"20350_CR15","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/978-1-4939-3673-1_5","volume":"1439","author":"A Yasgar","year":"2016","unstructured":"Yasgar, A., Jadhav, A., Simeonov, A. & Coussens, N. P. Alphascreen-based assays: Ultra-high-throughput screening for small-molecule inhibitors of challenging enzymes and protein-protein interactions. Methods Mol. Biol. 1439, 77\u201398 (2016).","journal-title":"Methods Mol. Biol."},{"key":"20350_CR16","doi-asserted-by":"publisher","first-page":"L379","DOI":"10.1152\/ajplung.00010.2008","volume":"295","author":"G Matute-Bello","year":"2008","unstructured":"Matute-Bello, G., Frevert, C. W. & Martin, T. R. Animal models of acute lung injury. Am. J. Physiol. Lung Cell. Mol. Physiol. 295, L379\u2013L399 (2008).","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"20350_CR17","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1097\/00024382-200013020-00004","volume":"13","author":"DG Remick","year":"2000","unstructured":"Remick, D. G., Newcomb, D. E., Bolgos, G. L. & Call, D. R. Comparison of the mortality and inflammatory response of two models of sepsis: lipopolysaccharide vs. cecal ligation and puncture. Shock 13, 110\u2013116 (2000).","journal-title":"Shock"},{"key":"20350_CR18","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1164\/ajrccm.165.3.2106050","volume":"165","author":"L Liaudet","year":"2002","unstructured":"Liaudet, L. et al. Activation of poly(ADP-Ribose) polymerase-1 is a central mechanism of lipopolysaccharide-induced acute lung inflammation. Am. J. Respir. Crit. Care Med. 165, 372\u2013377 (2002).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"20350_CR19","doi-asserted-by":"publisher","first-page":"15924","DOI":"10.1038\/s41598-021-95125-0","volume":"11","author":"S Bupp","year":"2021","unstructured":"Bupp, S. et al. A novel murine in vivo model for acute hereditary angioedema attacks. Sci. Rep. 11, 15924 (2021).","journal-title":"Sci. Rep."},{"key":"20350_CR20","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1177\/0192623315598399","volume":"43","author":"F Aeffner","year":"2015","unstructured":"Aeffner, F., Bolon, B. & Davis, I. C. Mouse models of acute respiratory distress syndrome: A review of analytical approaches, pathologic features, and common measurements. Toxicol. Pathol. 43, 1074\u20131092 (2015).","journal-title":"Toxicol. Pathol."},{"key":"20350_CR21","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1002\/med.21257","volume":"32","author":"S Magesh","year":"2012","unstructured":"Magesh, S., Chen, Y. & Hu, L. Small molecule modulators of Keap1-Nrf2-ARE pathway as potential preventive and therapeutic agents. Med. Res. Rev. 32, 687\u2013726 (2012).","journal-title":"Med. Res. Rev."},{"key":"20350_CR22","doi-asserted-by":"publisher","first-page":"1374425","DOI":"10.3389\/fimmu.2024.1374425","volume":"15","author":"M Ando","year":"2024","unstructured":"Ando, M. et al. The gut lactic acid bacteria metabolite, 10-oxo-cis-6,trans-11-octadecadienoic acid, suppresses inflammatory bowel disease in mice by modulating the NRF2 pathway and GPCR-signaling. Front. Immunol. 15, 1374425 (2024).","journal-title":"Front. Immunol."},{"key":"20350_CR23","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s10157-023-02427-w","volume":"28","author":"K Ikejiri","year":"2024","unstructured":"Ikejiri, K. et al. Effects of NRF2 polymorphisms on safety and efficacy of bardoxolone methyl: Subanalysis of TSUBAKI study. Clin. Exp. Nephrol. 28, 225\u2013234 (2024).","journal-title":"Clin. Exp. Nephrol."},{"key":"20350_CR24","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1093\/ndt\/gfac242","volume":"38","author":"M Nangaku","year":"2023","unstructured":"Nangaku, M. et al. Randomized, double-blind, placebo-controlled phase 3 study of bardoxolone methyl in patients with diabetic kidney disease: design and baseline characteristics of the AYAME study. Nephrol. Dial. Transpl. 38, 1204\u20131216 (2023).","journal-title":"Nephrol. Dial. Transpl."},{"key":"20350_CR25","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1038\/ki.2012.393","volume":"83","author":"Y Ding","year":"2013","unstructured":"Ding, Y. et al. The synthetic triterpenoid, RTA 405, increases the glomerular filtration rate and reduces angiotensin II-induced contraction of glomerular mesangial cells. Kidney Int. 83, 845\u2013854 (2013).","journal-title":"Kidney Int."},{"key":"20350_CR26","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1177\/0192623309343778","volume":"37","author":"RR Hukkanen","year":"2009","unstructured":"Hukkanen, R. R., Liggitt, H. D., Murnane, R. D. & Frevert, C. W. Systemic inflammatory response syndrome in nonhuman primates culminating in multiple organ failure, acute lung injury, and disseminated intravascular coagulation. Toxicol. Pathol. 37, 799\u2013804 (2009).","journal-title":"Toxicol. Pathol."},{"key":"20350_CR27","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1177\/1076029617709084","volume":"24","author":"A Walborn","year":"2018","unstructured":"Walborn, A., Hoppensteadt, D., Syed, D., Mosier, M. & Fareed, J. Biomarker profile of sepsis-associated coagulopathy using biochip assay for inflammatory cytokines. Clin. Appl. Thromb. Hemost. 24, 625\u2013632 (2018).","journal-title":"Clin. Appl. Thromb. Hemost."},{"key":"20350_CR28","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1097\/SHK.0000000000000331","volume":"43","author":"H Matsumoto","year":"2015","unstructured":"Matsumoto, H. et al. Enhanced expression of cell-specific surface antigens on endothelial microparticles in sepsis-induced disseminated intravascular coagulation. Shock 43, 443\u2013449 (2015).","journal-title":"Shock"},{"key":"20350_CR29","doi-asserted-by":"publisher","first-page":"107602962412713","DOI":"10.1177\/10760296241271358","volume":"30","author":"G Wang","year":"2024","unstructured":"Wang, G. et al. Exploring the mediating role of multiple organ dysfunction in sepsis-induced disseminated intravascular coagulation and its impact on worsening prognosis. Clin. Appl. Thromb. Hemost. 30, 10760296241271358 (2024).","journal-title":"Clin. Appl. Thromb. Hemost."},{"key":"20350_CR30","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/s13613-023-01216-8","volume":"13","author":"J Helms","year":"2023","unstructured":"Helms, J. et al. Disseminated intravascular coagulation is strongly associated with severe acute kidney injury in patients with septic shock. Ann. Intensive Care. 13, 119 (2023).","journal-title":"Ann. Intensive Care."},{"key":"20350_CR31","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s13613-024-01380-5","volume":"14","author":"T Iba","year":"2024","unstructured":"Iba, T., Helms, J. & Levy, J. H. Sepsis-induced coagulopathy (SIC) in the management of sepsis. Ann. Intensive Care. 14, 148 (2024).","journal-title":"Ann. Intensive Care."},{"key":"20350_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2023.116364","volume":"460","author":"Y Sun","year":"2023","unstructured":"Sun, Y. et al. Fibroblast growth factor 2 (FGF2) ameliorates the coagulation abnormalities in sepsis. Toxicol. Appl. Pharmacol. 460, 116364 (2023).","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"20350_CR33","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.thromres.2022.04.001","volume":"214","author":"J Shi","year":"2022","unstructured":"Shi, J. et al. NLRP3 inflammasome contributes to endotoxin-induced coagulation. Thromb. Res. 214, 8\u201315 (2022).","journal-title":"Thromb. Res."},{"key":"20350_CR34","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/0049-3848(89)90336-8","volume":"54","author":"T Tanaka","year":"1989","unstructured":"Tanaka, T. et al. Sepsis model with reproducible manifestations of multiple organ failure (MOF) and disseminated intravascular coagulation (DIC). Thromb. Res. 54, 53\u201361 (1989).","journal-title":"Thromb. Res."},{"key":"20350_CR35","doi-asserted-by":"publisher","first-page":"8825","DOI":"10.1126\/scitranslmed.3002011","volume":"3","author":"NM Goldenberg","year":"2011","unstructured":"Goldenberg, N. M., Steinberg, B. E., Slutsky, A. S. & Lee, W. L. Broken barriers: A new take on sepsis pathogenesis. Sci. Transl. Med. 3, 8825 (2011).","journal-title":"Sci. Transl. Med."},{"key":"20350_CR36","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.1046\/j.1523-1755.2001.00740.x","volume":"59","author":"M Knotek","year":"2001","unstructured":"Knotek, M. et al. Endotoxemic renal failure in mice: Role of tumor necrosis factor independent of inducible nitric oxide synthase. Kidney Int. 59, 2243\u20132249 (2001).","journal-title":"Kidney Int."},{"key":"20350_CR37","doi-asserted-by":"publisher","first-page":"848","DOI":"10.3109\/08860220903180632","volume":"31","author":"S Bansal","year":"2009","unstructured":"Bansal, S., Wang, W., Falk, S. & Schrier, R. Combination therapy with albumin and pentoxifylline protects against acute kidney injury during endotoxemic shock in mice. Ren. Fail. 31, 848\u2013854 (2009).","journal-title":"Ren. Fail."},{"key":"20350_CR38","doi-asserted-by":"publisher","first-page":"5817","DOI":"10.4049\/jimmunol.168.11.5817","volume":"168","author":"PN Cunningham","year":"2002","unstructured":"Cunningham, P. N. et al. Acute renal failure in endotoxemia is caused by TNF acting directly on TNF receptor-1 in kidney. J. Immunol. 168, 5817\u20135823 (2002).","journal-title":"J. Immunol."},{"key":"20350_CR39","doi-asserted-by":"publisher","first-page":"F546","DOI":"10.1152\/ajprenal.00072.2006","volume":"291","author":"RA Zager","year":"2006","unstructured":"Zager, R. A., Johnson, A. C., Lund, S. & Hanson, S. Acute renal failure: Determinants and characteristics of the injury-induced hyperinflammatory response. Am. J. Physiol. Renal. Physiol. 291, F546\u2013F556 (2006).","journal-title":"Am. J. Physiol. Renal. Physiol."},{"key":"20350_CR40","doi-asserted-by":"publisher","first-page":"F1453","DOI":"10.1152\/ajprenal.00485.2005","volume":"290","author":"RA Zager","year":"2006","unstructured":"Zager, R. A., Johnson, A. C., Lund, S., Hanson, S. Y. & Abrass, C. K. Levosimendan protects against experimental endotoxemic acute renal failure. Am. J. Physiol. Ren. Physiol. 290, F1453\u2013F1462 (2006).","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"20350_CR41","doi-asserted-by":"publisher","first-page":"F261","DOI":"10.1152\/ajprenal.00263.2006","volume":"292","author":"L Wu","year":"2007","unstructured":"Wu, L. et al. Peritubular capillary dysfunction and renal tubular epithelial cell stress following lipopolysaccharide administration in mice. Am. J. Physiol. Ren. Physiol. 292, F261\u2013F268 (2007).","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"20350_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2024.111030","volume":"396","author":"X Zhang","year":"2024","unstructured":"Zhang, X., Yuan, S., Fan, H., Zhang, W. & Zhang, H. Liensinine alleviates sepsis-induced acute liver injury by inhibiting the NF-kappaB and MAPK pathways in an Nrf2-dependent manner. Chem. Biol. Interact. 396, 111030 (2024).","journal-title":"Chem. Biol. Interact."},{"key":"20350_CR43","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.biopha.2016.06.036","volume":"83","author":"W Zhong","year":"2016","unstructured":"Zhong, W. et al. Curcumin alleviates lipopolysaccharide induced sepsis and liver failure by suppression of oxidative stress-related inflammation via PI3K\/AKT and NF-kappaB related signaling. Biomed. Pharmacother. 83, 302\u2013313 (2016).","journal-title":"Biomed. Pharmacother."},{"key":"20350_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e15436","volume":"9","author":"Y Sun","year":"2023","unstructured":"Sun, Y. et al. Astragaloside IV attenuates lipopolysaccharide induced liver injury by modulating Nrf2-mediated oxidative stress and NLRP3-mediated inflammation. Heliyon. 9, e15436 (2023).","journal-title":"Heliyon."},{"key":"20350_CR45","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/S0899-5885(18)30833-5","volume":"2","author":"BJ Lekander","year":"1990","unstructured":"Lekander, B. J. & Cerra, F. B. The syndrome of multiple organ failure. Crit. Care Nurs. Clin. N. Am. 2, 331\u2013342 (1990).","journal-title":"Crit. Care Nurs. Clin. N. Am."},{"key":"20350_CR46","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/s13613-024-01377-0","volume":"14","author":"A Borges","year":"2024","unstructured":"Borges, A. & Bento, L. Organ crosstalk and dysfunction in sepsis. Ann. Intensive Care. 14, 147 (2024).","journal-title":"Ann. Intensive Care."},{"key":"20350_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115914","volume":"169","author":"Y Jiang","year":"2023","unstructured":"Jiang, Y. et al. Pyroptosis in septic lung injury: Interactions with other types of cell death. Biomed. Pharmacother. 169, 115914 (2023).","journal-title":"Biomed. Pharmacother."},{"key":"20350_CR48","doi-asserted-by":"publisher","first-page":"868","DOI":"10.3892\/mmr.2021.12508","volume":"24","author":"S Li","year":"2021","unstructured":"Li, S., Lei, Y., Lei, J. & Li, H. All-trans retinoic acid promotes macrophage phagocytosis and decreases inflammation via inhibiting CD14\/TLR4 in acute lung injury. Mol. Med. Rep. 24, 868 (2021).","journal-title":"Mol. Med. Rep."},{"key":"20350_CR49","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/nprot.2008.214","volume":"4","author":"D Rittirsch","year":"2009","unstructured":"Rittirsch, D., Huber-Lang, M. S., Flierl, M. A. & Ward, P. A. Immunodesign of experimental sepsis by cecal ligation and puncture. Nat. Protoc. 4, 31\u201336 (2009).","journal-title":"Nat. Protoc."},{"key":"20350_CR50","doi-asserted-by":"publisher","first-page":"11624","DOI":"10.1038\/ncomms11624","volume":"7","author":"EH Kobayashi","year":"2016","unstructured":"Kobayashi, E. H. et al. Nrf2 suppresses macrophage inflammatory response by blocking proinflammatory cytokine transcription. Nat. Commun. 7, 11624 (2016).","journal-title":"Nat. Commun."},{"key":"20350_CR51","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1097\/01.CCM.0000055371.27268.36","volume":"31","author":"T Motoyama","year":"2003","unstructured":"Motoyama, T. et al. Possible role of increased oxidant stress in multiple organ failure after systemic inflammatory response syndrome. Crit. Care Med. 31, 1048\u20131052 (2003).","journal-title":"Crit. Care Med."},{"key":"20350_CR52","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1093\/bja\/aer093","volume":"107","author":"HF Galley","year":"2011","unstructured":"Galley, H. F. Oxidative stress and mitochondrial dysfunction in sepsis. Br. J. Anaesth. 107, 57\u201364 (2011).","journal-title":"Br. J. Anaesth."},{"key":"20350_CR53","doi-asserted-by":"publisher","first-page":"e307","DOI":"10.1016\/j.jss.2009.08.005","volume":"167","author":"M Andrades","year":"2011","unstructured":"Andrades, M. et al. Antioxidant treatment reverses organ failure in rat model of sepsis: role of antioxidant enzymes imbalance, neutrophil infiltration, and oxidative stress. J. Surg. Res. 167, e307\u2013e313 (2011).","journal-title":"J. Surg. Res."},{"key":"20350_CR54","doi-asserted-by":"publisher","first-page":"5985209","DOI":"10.1155\/2017\/5985209","volume":"2017","author":"K Mantzarlis","year":"2017","unstructured":"Mantzarlis, K., Tsolaki, V. & Zakynthinos, E. Role of oxidative stress and mitochondrial dysfunction in sepsis and potential therapies. Oxid. Med. Cell Longev. 2017, 5985209 (2017).","journal-title":"Oxid. Med. Cell Longev."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-20350-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-20350-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-20350-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T16:03:55Z","timestamp":1760717035000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-20350-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,17]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["20350"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-20350-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,17]]},"assertion":[{"value":"9 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Atsushi Kimbara is an inventor on a patent application (WO2023-JP211) related to the compound CH7450924 described in this study. All authors are employees of Chugai Pharmaceutical Co., Ltd.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Animal procedures and protocols were in accordance with the Guidelines for the Care and Use of Laboratory Animals at Chugai Pharmaceutical Co. Ltd. and approved by the Institutional Animal Care and Use Committee (approval No.21\u2013174, 23\u2013145, 24\u2013164, 24\u2013182, 24\u2013186, 24\u2013284) and were also compliance with the Animal Research: Reporting of In Vivo Experiments (ARRIVE) guidelines.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"36413"}}